Long-term administration of single-agent carboplatin (AUC 4) for advanced testicular seminoma safely achieved complete response in an 80-year-old man with chronic heart failure: A...

Por Fukuhara, Hiroki, Yagi, Mayu, Ando, Kaoru, Tomita, Yoshihiko
Publicado no Can Urol Assoc J (2014)

A Case of Myxoid Adrenocortical Neoplasm: Computed Tomography and Magnetic Resonance Imaging Characteristics

Por Fukuhara, Hiroki, Bilim, Vladimir, Ohtake, Hiroya, Yahagi, Yoshie, Tomita, Yoshihiko
Publicado em 2013

Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen

Por Takeda, Keisuke, Hara, Noboru, Nishiyama, Tsutomu, Tasaki, Masayuki, Ishizaki, Fumio, Tomita, Yoshihiko
Publicado no BMC Cancer (2016)

Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activi...

Por Ando, Takashi, Nishiyama, Tsutomu, Takizawa, Itsuhiro, Ishizaki, Fumio, Miyashiro, Yoshimichi, Takeda, Keisuke, Hara, Noboru, Tomita, Yoshihiko
Publicado no Sci Rep (2016)

GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition

Por Ito, Hiromi, Ichiyanagi, Osamu, Naito, Sei, Bilim, Vladimir N., Tomita, Yoshihiko, Kato, Tomoyuki, Nagaoka, Akira, Tsuchiya, Norihiko
Publicado no BMC Cancer (2016)

Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma

Por Eto, Masatoshi, Uemura, Hirotsugu, Tomita, Yoshihiko, Kanayama, Hiroomi, Shinohara, Nobuo, Kamei, Yoichi, Fujii, Yosuke, Umeyama, Yoshiko, Ozono, Seiichiro, Naito, Seiji, Akaza, Hideyuki
Publicado no Cancer Sci (2014)

Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 3 AXIS Trial

Por Ueda, Takeshi, Uemura, Hirotsugu, Tomita, Yoshihiko, Tsukamoto, Taiji, Kanayama, Hiroomi, Shinohara, Nobuo, Tarazi, Jamal, Chen, Connie, Kim, Sinil, Ozono, Seiichiro, Naito, Seiji, Akaza, Hideyuki
Publicado em 2013

Modified simultaneous integrated boost radiotherapy for large retroperitoneal malignant tumor: A case report

Por NOMIYA, TAKUMA, AKAMATSU, HIROKO, HARADA, MAYUMI, OTA, IBUKI, HAGIWARA, YASUHITO, ICHIKAWA, MAYUMI, MIWA, MISAKO, MIZUTANI, MASAOMI, KATO, TOMOYUKI, NAGAOKA, AKIRA, TOMITA, YOSHIHIKO, NEMOTO, KENJI
Publicado no Oncol Lett (2015)

Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study

Por Tomita, Yoshihiko, Fukasawa, Satoshi, Oya, Mototsugu, Uemura, Hirotsugu, Shinohara, Nobuo, Habuchi, Tomonori, Rini, Brian I., Chen, Ying, Bair, Angel H., Ozono, Seiichiro, Naito, Seiji, Akaza, Hideyuki
Publicado no Jpn J Clin Oncol (2016)

Identification of a set of genes associated with response to interleukin-2 and interferon-α combination therapy for renal cell carcinoma through genome-wide gene expression profili...

Por MIZUMORI, OSAMU, ZEMBUTSU, HITOSHI, KATO, YOICHIRO, TSUNODA, TATSUHIKO, MIYA, FUYUKI, MORIZONO, TAKASHI, TSUKAMOTO, TAIJI, FUJIOKA, TOMOAKI, TOMITA, YOSHIHIKO, KITAMURA, TADAICHI, OZONO, SEIICHIRO, MIKI, TSUNEHARU, NAITO, SEIJI, AKAZA, HIDEYUKI, NAKAMURA, YUSUKE
Publicado em 2010

Two-fraction high-dose-rate brachytherapy within a single day combined with external beam radiotherapy for prostate cancer: single institution experience and outcomes

Por Liu, Junyang, Kaidu, Motoki, Sasamoto, Ryuta, Ayukawa, Fumio, Yamana, Nobuko, Sato, Hiraku, Tanaka, Kensuke, Kawaguchi, Gen, Ohta, Atsushi, Maruyama, Katsuya, Abe, Eisuke, Kasahara, Takashi, Nishiyama, Tsutomu, Tomita, Yoshihiko, Aoyama, Hidefumi
Publicado no J Radiat Res (2016)

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction

Por Low, Siew-Kee, Fukunaga, Koya, Takahashi, Atsushi, Matsuda, Koichi, Hongo, Fumiya, Nakanishi, Hiroyuki, Kitamura, Hiroshi, Inoue, Takamitsu, Kato, Yoichiro, Tomita, Yoshihiko, Fukasawa, Satoshi, Tanaka, Tomoaki, Nishimura, Kazuo, Uemura, Hirotsugu, Hara, Isao, Fujisawa, Masato, Matsuyama, Hideyasu, Hashine, Katsuyoshi, Tatsugami, Katsunori, Enokida, Hideki, Kubo, Michiaki, Miki, Tsuneharu, Mushiroda, Taisei
Publicado no PLoS One (2016)

Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population

Por Matsuda, Koichi, Takahashi, Atsushi, Middlebrooks, Candace D., Obara, Wataru, Nasu, Yasutomo, Inoue, Keiji, Tamura, Kenji, Yamasaki, Ichiro, Naya, Yoshio, Tanikawa, Chizu, Cui, Ri, Figueroa, Jonine D., Silverman, Debra T., Rothman, Nathaniel, Namiki, Mikio, Tomita, Yoshihiko, Nishiyama, Hiroyuki, Kohri, Kenjiro, Deguchi, Takashi, Nakagawa, Masayuki, Yokoyama, Masayoshi, Miki, Tsuneharu, Kumon, Hiromi, Fujioka, Tomoaki, Prokunina-Olsson, Ludmila, Kubo, Michiaki, Nakamura, Yusuke, Shuin, Taro
Publicado no Hum Mol Genet (2015)

A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

Por Kawaguchi, Makoto, Hara, Noboru, Bilim, Vladimir, Koike, Hiroshi, Suzuki, Mituko, Kim, Tae-Sun, Gao, Nan, Dong, Yu, Zhang, Sheng, Fujinawa, Yuji, Yamamoto, Osamu, Ito, Hiromi, Tomita, Yoshihiko, Naruse, Yuchi, Sakamaki, Akira, Ishii, Yoko, Tsuneyama, Koichi, Inoue, Masaaki, Itoh, Johbu, Yasuda, Masanori, Sakata, Nobuo, Jung, Cha-Gyun, Kanazawa, Satoshi, Akatsu, Hiroyasu, Minato, Hiroshi, Nojima, Takayuki, Asai, Kiyofumi, Miura, Yutaka
Publicado no BMC Cancer (2016)